Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Francisca Llinares-Tello"'
Publikováno v:
Medicina Clínica. 147:410-416
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fff0bda6a897452000031f0cb1aebe25
https://doi.org/10.1016/j.medcli.2016.04.002
https://doi.org/10.1016/j.medcli.2016.04.002
Autor:
Lara Valor, José Rosas, Inmaculada de la Torre, Francisca Llinares-Tello, Senabre Jm, Xavier Barber
Publikováno v:
Reumatología Clínica (English Edition). 10:105-108
Objective To describe the results of the comparative study between both versions of an immunoassay commercialized for therapeutic drug monitoring of adalimumab (ADA) in rheumatoid arthritis (AR). Material and methods 140 samples of patients with RA t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7202ced8720bfa61b194b1240cc021c
https://doi.org/10.1016/j.reumae.2013.12.006
https://doi.org/10.1016/j.reumae.2013.12.006
Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis
Autor:
José, Rosas, Francisca, Llinares-Tello, José Miguel, Senabre-Gallego, Xavier, Barber-Vallés, Gregorio, Santos-Soler, Esteban, Salas-Heredia, Ana, Pons Bas, Catalina, Cano Pérez, Mario, García-Carrasco
Publikováno v:
Clinical and experimental rheumatology. 35(1)
Obesity can be a factor that affects response to anti-TNF drugs. However, studies on patients with ankylosing spondylitis (AS) are rare. We aimed to determine whether obesity affects serum levels of adalimumab (ADL), and immunogenicity and clinical e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ec5714ac447ed08166d21d6180cbf1e5
https://pubmed.ncbi.nlm.nih.gov/27908311
https://pubmed.ncbi.nlm.nih.gov/27908311
Publikováno v:
Medicina clinica. 147(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa03418bb1a1a5f0a30ae105682dbdb4
https://pubmed.ncbi.nlm.nih.gov/27216221
https://pubmed.ncbi.nlm.nih.gov/27216221
Autor:
Francisca Llinares-Tello, José Rosas-Gómez de Salazar, José Miguel Senabre-Gallego, Gregorio Santos-Soler, Carlos Santos-Ramírez, Esteban Salas-Heredia, Juan Molina-García, null the AIRE-MB Group
Publikováno v:
Clinical chemistry and laboratory medicine. 53(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4d37976bff3e7a1291adb6730a98664
https://pubmed.ncbi.nlm.nih.gov/26021413
https://pubmed.ncbi.nlm.nih.gov/26021413
Autor:
José, Rosas, Francisca, Llinares-Tello, Inmaculada, de la Torre, Carlos, Santos-Ramírez, José Miguel, Senabre-Gallego, Lara, Valor, Xavier, Barber-Vallés, Diana, Hernández-Flórez, Gregorio, Santos-Soler, Esteban, Salas-Heredia, Luis, Carreño, Mario, García-Carrasco
Publikováno v:
Clinical and experimental rheumatology. 32(6)
The aim of this paper is to assess the usefulness of measuring serum levels of adalimumab (ADL) and anti-ADL antibodies in 57 patients with rheumatoid arthritis (RA) treated with ADL for at least 3 months in daily practice.All patients received conco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2fcd52f86072ef26bbfb61615540e1d1
https://pubmed.ncbi.nlm.nih.gov/25327159
https://pubmed.ncbi.nlm.nih.gov/25327159
Publikováno v:
cclm. 38:1039-1042
We evaluated the analytical performance of the Immulite 2000® immunoassay analyzer (Diagnostic Products Corporation, Los Angeles, USA) based on a new detection technology, electrochemical luminescence. The evaluated analytes were thyrotropin, triiod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46b521977c64fa01039cad41fc298a30
https://doi.org/10.1515/cclm.2000.154
https://doi.org/10.1515/cclm.2000.154
Autor:
Ismael Pastor-Climente, Francisca Llinares-Tello, Carmen Hernández-Prats, Salvador Escrivá-Moscardó, Elena Moreno-Guillamont, Mary Martínez-Martínez
Publikováno v:
Revista Española de Geriatría y Gerontología. 42:86-88
Resumen El objetivo de este estudio consiste en determinar el estado nutricional de los 83 residentes de un centro sociosanitario y evaluar su evolucion tras la aplicacion del protocolo de valoracion nutricional disenado a tal efecto desde la Conseje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba9b3337c02030e721a198ab19e912c4
https://doi.org/10.1016/s0211-139x(07)73591-6
https://doi.org/10.1016/s0211-139x(07)73591-6
Autor:
Francisca, Llinares-Tello, José, Rosas-Gómez de Salazar, José Miguel, Senabre-Gallego, Gregorio, Santos-Soler, Carlos, Santos-Ramírez, Esteban, Salas-Heredia, Xavier, Barber-Vallés, Juan, Molina-García, Mabel, Sánchez Barrioluengo
Publikováno v:
Rheumatology international. 34(12)
Patients treated with adalimumab (ADL) can induce anti-ADL antibodies (AAA) formation that is associated with low drug levels and clinical non-response. But, in the majority of the assays, the measurement of AAA is hampered by the presence of the dru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77bbea7c90221c05074dba7e703345ea
https://pubmed.ncbi.nlm.nih.gov/24816715
https://pubmed.ncbi.nlm.nih.gov/24816715
Autor:
Francisca, Llinares-Tello, José, Rosas, Inmaculada, de la Torre, Lara, Valor, Xavier, Barber, José Miguel, Senabre, Luis, Carreño
Publikováno v:
Reumatologia clinica. 10(2)
To describe the results of the comparative study between both versions of an immunoassay commercialized for therapeutic drug monitoring of adalimumab (ADA) in rheumatoid arthritis (AR).140 samples of patients with RA treated with ADA 40mg every 14 da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::96de86b1c6d2e883ab85db5e469dad3e
https://pubmed.ncbi.nlm.nih.gov/24035361
https://pubmed.ncbi.nlm.nih.gov/24035361